EPANOVA in Crohn's Disease, Study 1 (EPIC-1)
This study has been completed.
Sponsor:
Tillotts Pharma AG
Information provided by:
Tillotts Pharma AG
ClinicalTrials.gov Identifier:
NCT00613197
First received: January 15, 2008
Last updated: April 3, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | August 2006 |
| Primary Completion Date: | August 2006 (Final data collection date for primary outcome measure) |
No publications provided by Tillotts Pharma AG
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):